Reply to "Critical Evaluation of HER2 PET Imaging in Metastatic Breast Cancer: Addressing Key Challenges and Future Directions" and "The Role of HER2 PET in Treatment of Breast Cancer"

J Nucl Med. 2026 Feb 2;67(2):325-326. doi: 10.2967/jnumed.125.271241.
No abstract available

Publication types

  • Letter